UniSuper Management Pty Ltd increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,789 shares of the healthcare conglomerate's stock after buying an additional 12,587 shares during the quarter. UniSuper Management Pty Ltd's holdings in UnitedHealth Group were worth $51,997,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the company. Howard Capital Management Group LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. grew its position in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after acquiring an additional 180,479 shares during the period. Algert Global LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at $1,763,000. Cadence Bank raised its position in shares of UnitedHealth Group by 1.7% in the third quarter. Cadence Bank now owns 2,794 shares of the healthcare conglomerate's stock valued at $1,634,000 after purchasing an additional 46 shares during the period. Finally, Baldwin Investment Management LLC grew its position in shares of UnitedHealth Group by 2.7% in the third quarter. Baldwin Investment Management LLC now owns 2,800 shares of the healthcare conglomerate's stock valued at $1,637,000 after purchasing an additional 74 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on UNH. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. KeyCorp reaffirmed an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Finally, Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $629.32.
View Our Latest Research Report on UNH
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded down $0.25 during midday trading on Friday, hitting $515.47. 2,378,211 shares of the company's stock traded hands, compared to its average volume of 4,268,981. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $471.51 billion, a price-to-earnings ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The firm has a fifty day moving average of $508.81 and a 200 day moving average of $544.24.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.83 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.
Insiders Place Their Bets
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company's stock.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.